Kieran Horgan Selected Research

Kieran Horgan Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2003
21	Neoplasms (Cancer) 12/2023 - 08/2006
3	Frailty 11/2023 - 08/2019
2	COVID-19 06/2023 - 07/2020
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Fatigue 01/2021 - 01/2021
2	Wounds and Injuries (Trauma) 01/2021 - 02/2011
1	Cicatrix (Scar) 03/2022
1	Vomiting 01/2021
1	Constipation 01/2021
1	Seroma 01/2021
1	Nausea 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2019
1	Calcinosis 01/2018
1	Pathologic Complete Response 01/2018
1	Tetanus 01/2016
1	Liposarcoma 12/2013
1	Ductal Carcinoma 01/2013
1	Intussusception 01/2013
1	Male Breast Neoplasms (Male Breast Cancer) 09/2011
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 06/2009
1	Abdominal Pain (Pain, Abdominal) 06/2009
1	Neoplasm Metastasis (Metastasis) 05/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2022 - 08/2012
4	Estrogen Receptor alphaIBA 10/2011 - 08/2006
3	Aromatase InhibitorsIBA 12/2023 - 09/2011
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2020
3	Tamoxifen FDA LinkGeneric 10/2011 - 01/2008
2	Anastrozole (Arimidex)FDA LinkGeneric 12/2023 - 11/2020
2	Letrozole (Femara)FDA LinkGeneric 12/2023 - 11/2020
2	Hormones (Hormone)IBA 10/2023 - 11/2020
2	capivasertibIBA 12/2022 - 01/2020
2	AntibodiesIBA 01/2016 - 01/2014
2	multidrug resistance-associated protein 1IBA 09/2015 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 12/2013 - 01/2013
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2011 - 08/2006
2	Androgen Receptors (Androgen Receptor)IBA 10/2011 - 09/2011
2	Estrogen Receptor betaIBA 09/2010 - 08/2006
1	pertuzumabIBA 11/2023
1	Lapatinib (GW572016)FDA Link 01/2022
1	SuspensionsIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Progesterone FDA LinkGeneric 11/2016
1	AntigensIBA 01/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2015
1	Small Interfering RNA (siRNA)IBA 03/2014
1	ATP dependent 26S protease (26S proteasome)IBA 03/2014
1	GemininIBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2013
1	ParaffinIBA 01/2013
1	XenobioticsIBA 01/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2013
1	polatuzumab vedotinIBA 11/2012
1	MicroRNAs (MicroRNA)IBA 08/2012
1	Circulating MicroRNAIBA 08/2012
1	Fulvestrant (Faslodex)FDA Link 09/2011
1	ProlactinIBA 09/2011
1	Serine (L-Serine)FDA Link 09/2010
1	Carcinoembryonic AntigenIBA 01/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Estrogen ReceptorsIBA 08/2006
1	TransferasesIBA 10/2003
1	DNA (Deoxyribonucleic Acid)IBA 10/2003

Therapy/Procedure

15	Therapeutics 03/2024 - 01/2008
11	Drug Therapy (Chemotherapy) 11/2023 - 11/2012
6	Radiotherapy 03/2024 - 05/2006
5	Mastectomy (Mammectomy) 03/2024 - 11/2012
3	Neoadjuvant Therapy 01/2018 - 01/2013
2	Segmental Mastectomy (Lumpectomy) 03/2024 - 11/2023
1	Duration of Therapy 10/2023
1	Catheters 03/2022
1	Animal Assisted Therapy 01/2021
1	Critical Care (Surgical Intensive Care) 07/2020
1	Adjuvant Chemotherapy 01/2020
1	Adjuvant Radiotherapy 08/2019
1	Colectomy 01/2013
1	Conversion to Open Surgery 01/2013
1	Mammaplasty (Breast Reconstruction) 11/2012
1	Antibiotic Prophylaxis 02/2011
1	Cesarean Section (Caesarean Section) 06/2009